SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
73 hedge funds and large institutions have $103M invested in Sierra Oncology, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 29 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $115M → $103M (-$12.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $21K
Holders
73
Holding in Top 10
4
Calls
–
Puts
$21K
Top Buyers
| 1 | +$6.44M | |
| 2 | +$5.25M | |
| 3 | +$4.6M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.62M |
| 5 |
A
Abingworth
London,
United Kingdom
|
+$2.98M |
Top Sellers
| 1 | -$2.07M | |
| 2 | -$1M | |
| 3 | -$250K | |
| 4 |
JG
Jefferies Group
New York
|
-$224K |
| 5 |
Two Sigma Investments
New York
|
-$178K |